Sensitivity and Specificity of International Prostate Symptom Score (IPSS) for the screening of iranian patients with prostate cancer

Acta Medica Iranica

Volumn 49, Issue 7, 2011, Pages 451-455

  Hosseini, Mostafa ^a   Ebrahimi, Seyed Meisam ^a   SeyedAlinaghi, SeyedAhmad ^b   Mahmoodi, Mahmood ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

International Prostate Symptom Score; Rostate cancer; Sensitivity; Specificity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; IRAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION; PROSTATE CANCER; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY;

CASE-CONTROL STUDIES; HUMANS; IRAN; MALE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 80053224590     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006;56(2):106-30.
2. Godley PA, Carpenter WR. Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms. J Clin Epidemiol 2007;60(2):176-80.
3. Hosseini M, Seyed Alinaghi S, Mahmoudi M, McFarland W. A case-control study of risk factors for prostate cancer in Iran. Acta Med Iran 2010;48(1):61-6.
4. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147(3 Pt 2):815-6.
5. Mettlin C, Littrup PJ, Kane RA, Murphy GP, Lee F, Chesley A, Badalament R, Mostofi FK. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project. Cancer 1994;74(5):1615-20.
6. Brawer MK, Meyer GE, Letran JL, Bankson DD, Morris DL, Yeung KK, Allard WJ. Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology 1998;52(3):372-8.
7. Okamura K, Usami T, Nagahama K, Maruyama S, Mizuta E. "Quality of life" assessment of urination in elderly Japanese men and women with some medical problems using International Prostate Symptom Score and King's Health Questionnaire. Eur Urol 2002;41(4):411-9.
8. Pinnock C, Marshall VR. Troublesome lower urinary tract symptoms in the community: a prevalence study. Med J Aust 1997;167(2):72-5.
9. Tsukamoto T, Kumamoto Y, Masumori N, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995;154(2 Pt 1):391-5.
10. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999;83(4):410-5.
11. Madersbacher S, Pycha A, Klingler CH, Schatzl G, Marberger M. The International Prostate Symptom score in both sexes: a urodynamics-based comparison. Neurourol Urodyn 1999;18(3):173-82.
12. rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006. p. 525-33.
13. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148(5):1549-57; discussion 1564.
14. Chai TC, Belville WD, McGuire EJ, Nyquist L. Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes. J Urol 1993;150(5 Pt 2):1710-3.
15. Chancellor MB, Rivas DA. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J Urol 1993;150(5 Pt 2):1706-8; discussion 1708-9.
16. van Haarst EP, Heldeweg EA, Newling DW, Schlatmann TJ. A cross-sectional study of the international prostate symptom scores related to age and gender in Dutch adults reporting no voiding complaints. Eur Urol 2005;47(3):334-9.
17. Okamura K, Usami T, Nagahama K, Maruyama S, Mizuta E. The relationships among filling, voiding subscores from International Prostate Symptom Score and quality of life in Japanese elderly men and women. Eur Urol 2002;42(5):498-505.
18. Sommer P, Nielsen KK, Bauer T, Kristensen ES, Hermann GG, Steven K, Nordling J. Voiding patterns in men evaluated by a questionnaire survey. Br J Urol 1990;65(2):155-60.